Daniel E. Greenleaf

2016

In 2016, Daniel E. Greenleaf earned a total compensation of $1.6M as President & Chief Executive Officer at BioScrip.

Compensation breakdown

Non-Equity Incentive Plan$362,500
Option Awards$621,041
Salary$207,635
Stock Awards$418,867
Other$25,000
Total$1,635,043

Greenleaf received $621K in option awards, accounting for 38% of the total pay in 2016.

Greenleaf also received $362.5K in non-equity incentive plan, $207.6K in salary, $418.9K in stock awards and $25K in other compensation.

Rankings

In 2016, Daniel E. Greenleaf's compensation ranked 5,850th out of 14,075 executives tracked by ExecPay. In other words, Greenleaf earned more than 58.4% of executives.

ClassificationRankingPercentile
All
5,850
out of 14,075
58th
Division
Services
1,023
out of 2,282
55th
Major group
Health Services
91
out of 209
57th
Industry group
Home Health Care Services
12
out of 30
60th
Industry
Home Health Care Services
12
out of 30
60th
Source: SEC filing on April 5, 2017.

Greenleaf's colleagues

We found seven more compensation records of executives who worked with Daniel E. Greenleaf at BioScrip in 2016.

2016

Richard Smith

BioScrip

Chief Executive Officer

2016

J Luthin

BioScrip

Chief Operating Officer

2016

Brian Stiver

BioScrip

Former Senior Vice President, Sales & Marketing

2016

Jeffrey Kreger

BioScrip

Chief Financial Officer

2016

Britt Jeffcoat

BioScrip

Chief Accounting Officer

2016

David Evans

BioScrip

Chief Operating Officer

2016

Alex Schott

BioScrip

Senior Vice President, Strategic Operations

News

You may also like